# The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012, Regulation 33: Interpretation


In this Part—
“health care intervention” includes the use of a medicine or medical device, diagnostic technique, surgical procedure or other therapeutic intervention;
“NICE” means—
(a)until the coming into force of section 232 of the 2012 Act , the National Institute for Health and Clinical Excellence ; and
(b)from the coming into force of that section, the National Institute for Health and Care Excellence;
“relevant NICE recommendations” means—
(a)any directions given by the Secretary of State as to the application of sums paid to a Primary Care Trust under section 228 of the 2006 Act (public funding by Primary Care Trusts) in relation to a health care intervention recommended by NICE; and
(b)from the coming into force of section 237(8) of the 2012 Act (NICE advice, guidance, information and recommendations), recommendations specified, or recommendations of a description specified, in regulations made under that section where the relevant body—
(i)is specified in such regulations as required to comply with the recommendation, or
(ii)is a health and social care body of a description specified in such regulations as a health and social care body that is required to comply with the recommendation.

---
Source: https://www.legislation.gov.uk/uksi/2012/2996/regulation/33 (the official version)
Page: https://openlegislation.uk/national-health-service-commissioning-board-and-clinical-commissioning-groups-responsibilities-and-standing-rules-regulations-2012/regulation-33
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

